OSAAI 2019: Northwest Allergy Forum

Portland, OR US
October 4, 2019 to October 6, 2019

OSAAI members: $100
Non-members: $125
Allied health professionals: $50
Fellows-in-training, Residents, Medical Students: Free
Retired physicians: $50

Note: Price is adjusted from the regular price by selecting an option on the REGISTER tab.

The Northwest Allergy Forum is a CME educational meeting jointly provided by the American College of Allergy, Asthma & Immunology and the Oregon and Washington Societies of Allergy, Asthma & Immunology. The program is a two-day event with speakers covering a range of topics such as asthma, eczema, food allergy, vocal cord dysfunction and research developments.

Check the VENUE tab above for hotel information!

Accreditation 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Oregon Society of Allergy, Asthma & Immunology (OSAAI).  The American College of Allergy, Asthma and Immunology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of  9 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Target Audience

Practicing allergists
Allied health professionals

Learning Objectives

  1. Appraise the current state of food allergy diagnosis and treatment
  2. Integrate current biologic therapies into management of eczema and asthma
  3. Evaluate and support patients with chronic cough and vocal cord dysfunction
  4. Summarize proper evaluation and management of drug allergy
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months.  All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations.  It is required that disclosure be provided to the learners prior to the start of the activity.  Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist.  Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.  Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.  Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

The individuals listed below disclose the following financial relationships: 
Alan Baptist, MD – Speaker
Independent Contractor: American Lung Association, Novartis
Advisory Board Member: Teva

Andrew Blauvelt, MD, MBA – Speaker
Advisory Board Member: Abbvie Aclaris, Akros, Allergan, Almirall, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers  Squibb, Celgene, Dermira, Inc., Eli Lilly & Co., FLX Bio, Galderma, Genetech/Roche, GlaxoSmithKline, Janssen, Leo, Meiji, Merck Sharp & Dohme,  Novartis, Pfizer, Purdue Pharma, Rengeneron, Revance, Sandoz, Sanofi Genzyme, Sienna Pharmaceuticals, Sun Pharma, UCB Pharma, Valeant, Vidac 
Consultant:  Abbvie Aclaris, Akros, Allergan, Almirall, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers  Squibb, Celgene, Dermira, Inc., Eli Lilly & Co., FLX Bio, Galderma, Genetech/Roche, GlaxoSmithKline, Janssen, Leo, Meiji Merck Sharp & Dohme,  Novartis, Pfizer, Purdue Pharma, Rengeneron, Revance, Sandoz, Sanofi Genzyme, Sienna Pharmaceuticals, Sun Pharma, UCB Pharma, Valeant, Vidac 
Speaker: Abbvie, Janssen, Rengeneron, Sanofi Genzyme

Warner W. Carr, MD FACP, FAAAAI, FACAAI – Speaker
Consultant: AstraZeneca, Regeneron, Sanofi, Teva
Speaker: AstraZeneca, Regeneron, Sanofi, Optinose

Matthew Greenhawt, MD, MBA, MSc – Speaker
Speaker: ACAAI, Aimmune, Allergy & Asthma Network, Before Brands, Canadian Society of Allergy & Clinical Immunology, DBV, EAACI, Eastern Allergy Society, FL Society of Allergy & Immunology, Kansas City Allergy Society, Medscape, N. CA Allergy Society, Thermo Fisher
Advisory Board Member: Aimmune, Allergenis, Aquestive, DBV, Genentech, Intrommune, Kaléo, Monsanto, Nestlé, Nutricia, Prota, Sanofi/Genzyme
Consultant: Aimmune, Canadian Transportation Agency, Thermo Fisher
Principal Investigator: AHRQ, DBV BIOPOT
Employment: ACAAI, University of Colorado

Adam Williams, MD – Planner
Speaker: AstraZeneca, Novartis

Melanie Wayne, FNP – Planner
Author: CSL
Speaker: Shire

The following have no relevant financial relationships to disclose:
Karen Drake, MA, CCC-SP – Speaker
Shyam Joshi, MD – Speaker
Joshua Schindler, MD – Speaker
Raj Srinivasan, MD – Presenter, Planner
Justin Treat, DO – Planner
James Baker, MD – Planner
Karol Anderson – Planner
 

 
Course summary
Available credit: 
  • 9.00 AMA PRA Category 1 Credit™
  • 9.00 Attendance
Course opens: 
03/11/2019
Course expires: 
03/10/2021
Event starts: 
10/04/2019 - 3:00pm
Event ends: 
10/06/2019 - 4:30pm
Cost:
$125.00
Rating: 
0
Friday, Oct. 4th5:00-7:00pm   Welcome/Registration  
  
Saturday, Oct. 5th 
7:00am-7:50amExhibits | Registration | Continental Breakfast
8:00am-9:00am Asthma in Older Adults – A Different Disease?  Alan Baptist, MD
9:00-10:00amData Update on Dupilumab for Atopic Dermatitis  Andrew Blauvelt, MD
10:00-11:00amBiologics in Asthma Warner Carr, MD
11:00-11:30amCoffee Break | Exhibits
11:30am-12:30pmVocal Cord Dysfunction and Functional Breathing Disorders Joshua Schindler, MD
12:30-1:30pmParadoxical Vocal fold Motion: Differential Diagnosis: Evaluation & Treatment Karen Drake, M.A., CCC-SP
1:30pmAdjourn
1:30-2:30pmState Societies Lunch Meeting(s)
  
Sunday, Oct. 6th 
7:00am-8:00amExhibits| Registration | Continental Breakfast
8:00-9:00amHealth Economics of Food Allergy – Matthew Greenhawt, MD
9:00-10:00amThe Burgeoning Therapeutic Pipeline for Atopic Dermatitis- Andrew Blauvelt, MD
10:00-10:20amCoffee Break | Exhibits
10:20-11:20amRisk of Public Exposure and Thresholds of Peanuts - Matthew Greenhawt, MD
11:20-12:20pmDrug Allergies: Beyond Penicillin - Shyam Joshi, MD
12:20pmAdjourn
12:25pmFarewell Lunch Sponsored by OSAAI

Target Audience
Practicing allergists, primary care physicians, and allied health care providers in the field of allergy and immunology.

Learning Objectives
Upon completion of this activity, participants should be able to:
- Appraise the current state of food allergy diagnosis and treatment
- Integrate current biologic therapies into management of eczema and asthma
- Evaluate and support patients with chronic cough and vocal cord dysfunction
- Summarize proper evaluation and management of drug allergy

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma and Immunology (ACAAI) and the Oregon Society of Allergy, Asthma and Immunology (OSAAI).  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation
The American College of Allergy, Asthma and Immunology (ACAAI) designates this live activity for a maximum of 9 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
This activity is supported by commercial interests

 In compliance with the Americans with Disabilities Act, OSAAI requests that any participant in need of accommodation contact osaai@osaai.org

Portland Marriott Downtown Waterfront
1401 SW Naito Parkway
Portland, OR 97201
United States

Please use the link below to access hotel information:

https://book.passkey.com/e/49802106

Alan Baptist, MD, MPH
Andrew Blauvelt, MD, MBA
Warner Carr, MD
Karen Drake, MA, CCC-SP
Matthew Greenhawt, MD, MBA, MSc
Shyam Joshi, MD
Joshua Schindler, MD

 

 

 

 

 

Available Credit

  • 9.00 AMA PRA Category 1 Credit™
  • 9.00 Attendance

Accreditation Period

Course opens: 
03/11/2019
Course expires: 
03/10/2021

Price

Cost:
$125.00
Please login or create an account to take this course.